A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function
Clinical trial NCT04237831 · COMPLETED
Trial details
- NCT number
- NCT04237831
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-26
- Primary completion
- 2021-07-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.